IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study
Article Date
April 28, 2023
This article is featured on another website.
Go to article
September 5, 2023
David Topper Joined Inmagene as CFO
September 5, 2023
David Topper Joined Inmagene as CFO
September 19, 2023
Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development
September 19, 2023